368 related articles for article (PubMed ID: 17471532)
1. Paradoxical roles for lysyl oxidases in cancer--a prospect.
Payne SL; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2007 Aug; 101(6):1338-54. PubMed ID: 17471532
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
3. A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
[TBL] [Abstract][Full Text] [Related]
4. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase in development, aging and pathologies of the skin.
Szauter KM; Cao T; Boyd CD; Csiszar K
Pathol Biol (Paris); 2005 Sep; 53(7):448-56. PubMed ID: 16085123
[TBL] [Abstract][Full Text] [Related]
6. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
Payne SL; Fogelgren B; Hess AR; Seftor EA; Wiley EL; Fong SF; Csiszar K; Hendrix MJ; Kirschmann DA
Cancer Res; 2005 Dec; 65(24):11429-36. PubMed ID: 16357151
[TBL] [Abstract][Full Text] [Related]
7. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase: a potential target for cancer therapy.
Siddikuzzaman ; Grace VM; Guruvayoorappan C
Inflammopharmacology; 2011 Jun; 19(3):117-29. PubMed ID: 21107914
[TBL] [Abstract][Full Text] [Related]
9. Lysyl oxidase as a potential therapeutic target.
Rodríguez C; Rodríguez-Sinovas A; Martínez-González J
Drug News Perspect; 2008 May; 21(4):218-24. PubMed ID: 18560621
[TBL] [Abstract][Full Text] [Related]
10. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis.
Shieh TM; Lin SC; Liu CJ; Chang SS; Ku TH; Chang KW
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4378-85. PubMed ID: 17671119
[TBL] [Abstract][Full Text] [Related]
11. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.
Payne SL; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2006 Jul; 98(4):827-37. PubMed ID: 16440329
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis].
Liu JL; Wei W; Tang W; Jiang Y; Yang HW; Li JT
Zhonghua Yi Xue Za Zhi; 2012 May; 92(20):1379-83. PubMed ID: 22883193
[TBL] [Abstract][Full Text] [Related]
14. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
[TBL] [Abstract][Full Text] [Related]
15. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.
Bouez C; Reynaud C; Noblesse E; Thépot A; Gleyzal C; Kanitakis J; Perrier E; Damour O; Sommer P
Clin Cancer Res; 2006 Mar; 12(5):1463-9. PubMed ID: 16533769
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.
Peyrol S; Raccurt M; Gerard F; Gleyzal C; Grimaud JA; Sommer P
Am J Pathol; 1997 Feb; 150(2):497-507. PubMed ID: 9033266
[TBL] [Abstract][Full Text] [Related]
17. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
[TBL] [Abstract][Full Text] [Related]
19. Morpholino knockdown of lysyl oxidase impairs zebrafish development, and reflects some aspects of copper metabolism disorders.
Reynaud C; Baas D; Gleyzal C; Le Guellec D; Sommer P
Matrix Biol; 2008 Jul; 27(6):547-60. PubMed ID: 18467084
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
Fujimoto E; Tajima S
J Dermatol Sci; 2009 Aug; 55(2):91-8. PubMed ID: 19394199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
